KS
Kalathilparambath Sujil
About Kalathilparambath Sujil
Data last updated:
Kalathilparambath Sujil is a Director at Baylor Pharmaceutical Private Limited (since 2023), Director at Baylor Cv Pharmaceutical Private Limited (since 2026) and Designated Partner at Baylor Urotech Pharmaceutical Llp (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Baylor Pharmaceutical Private Limited at ₹4.54 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Baylor Pharmaceutical Private Limited U85110MH2019PTC326121 | Director | 15 Dec 2023 | 2019 | ₹4.54 Cr (FY 2025) | Active |
 Baylor Cv Pharmaceutical Private Limited U46497MR2026PTC479585 | Director | 11 Aug 2026 | 2026 | Active | |
| Baylor Urotech Pharmaceutical Llp ACP-3815 | Designated Partner | 24 Jun 2025 | 2025 | Active |
Board colleagues of Kalathilparambath Sujil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anoop Murali | 10423937 | Baylor Pharmaceutical Private Limited | Director |
| Cheruliyil Mithun Das | 10424001 | Baylor Pharmaceutical Private Limited , Baylor Urotech Pharmaceutical Llp | Director |
| Edadan Puthiyaveedu Suhesh | 09158223 | Baylor Pharmaceutical Private Limited , Baylor Cv Pharmaceutical Private Limited | Director |
| Kandamkulngara Aneesh | 09181237 | Baylor Pharmaceutical Private Limited | Director |
| Panni Prashob | 09086346 | Baylor Pharmaceutical Private Limited | Director |
| Sujesh Vallathana | 11004327 | Baylor Pharmaceutical Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalathilparambath Sujil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalathilparambath Sujil
Kalathilparambath Sujil currently holds 3 directorships: Baylor Pharmaceutical Private Limited (Director, since 15 Dec 2023, revenue ₹4.54 Cr (FY 2025)); Baylor Cv Pharmaceutical Private Limited (Director, since 11 Aug 2026); Baylor Urotech Pharmaceutical Llp (Designated Partner, since 24 Jun 2025).
Kalathilparambath Sujil was first appointed on 15 Dec 2023 as Director at Baylor Pharmaceutical Private Limited. The most recent appointment on record is 11 Aug 2026 at Baylor Cv Pharmaceutical Private Limited.
The current boards of Kalathilparambath Sujil's companies include Anoop Murali (Baylor Pharmaceutical Private Limited), Cheruliyil Mithun Das (Baylor Pharmaceutical Private Limited), Edadan Puthiyaveedu Suhesh (Baylor Pharmaceutical Private Limited), Kandamkulngara Aneesh (Baylor Pharmaceutical Private Limited), Panni Prashob (Baylor Pharmaceutical Private Limited), Sujesh Vallathana (Baylor Pharmaceutical Private Limited).